Novartis AG (NVS) CEO Vasant Narasimhan - CEO on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 10/22/19
Novartis Delivers In Breast Cancer Study, Could Lead To A Major Battle With CompetitorsSeeking Alpha • 10/09/19
Bausch files suit against Novartis unit Sandoz for infringing patents on Xifaxan 550 mg tabletsMarket Watch • 10/01/19
Novartis Continues To Make Significant Strides Toward Boosting Sales Of CosentyxSeeking Alpha • 09/24/19
Novartis Presses Forward With Plan To Get New Treatment Options For Subset Of NSCLC PopulationSeeking Alpha • 09/13/19
Novartis Wants A Piece Of MS Market; Latest Data In Head-To-Head Studies Might Be The KeySeeking Alpha • 09/12/19